Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RADIUM RA-223 DICHLORIDE for Osteosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where RADIUM RA-223 DICHLORIDE was used for Osteosarcoma.

Most Reported Side Effects for RADIUM RA-223 DICHLORIDE

Side Effect Reports % Deaths Hosp.
Prostatic specific antigen increased 449 9.3% 58 61
Hormone-refractory prostate cancer 441 9.2% 154 66
Death 376 7.8% 374 85
Anaemia 324 6.7% 97 149
Metastases to bone 315 6.5% 50 37
General physical health deterioration 308 6.4% 77 105
Fatigue 242 5.0% 36 59
Haemoglobin decreased 236 4.9% 41 72
Prostate cancer 234 4.9% 72 46
Nausea 221 4.6% 39 91
Pain 215 4.5% 41 77
Disease progression 208 4.3% 19 14
Diarrhoea 205 4.3% 33 71
Malaise 196 4.1% 40 97
Platelet count decreased 189 3.9% 63 78

Other Indications for RADIUM RA-223 DICHLORIDE

Hormone-refractory prostate cancer (1,615) Metastases to bone (1,501) Prostate cancer (541) Prostate cancer metastatic (445) Prostate cancer stage iv (365) Product used for unknown indication (84) Metastasis (76) Metastases to lymph nodes (12) Metastases to bone marrow (10) Cancer pain (8)

Other Drugs Used for Osteosarcoma

METHOTREXATE (1,267) DOXORUBICIN (1,135) CISPLATIN (975) IFOSFAMIDE (845) ETOPOSIDE (531) CARBOPLATIN (169) CABOZANTINIB S-MALATE (116) DOCETAXEL (99) CYCLOPHOSPHAMIDE (92) LENVATINIB (91)

Related Pages

RADIUM RA-223 DICHLORIDE Full Profile All Osteosarcoma Drugs RADIUM RA-223 DICHLORIDE Demographics RADIUM RA-223 DICHLORIDE Timeline